Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
about
High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.Hyperglycemia impairs atherosclerosis regression in mice.Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes?Direct effects of PPARα agonists on retinal inflammation and angiogenesis may explain how fenofibrate lowers risk of severe proliferative diabetic retinopathy.
P2860
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@en
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@nl
type
label
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@en
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@nl
prefLabel
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@en
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@nl
P2860
P921
P356
P1476
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
@en
P2093
Christoph Wanner
Vera Krane
P2860
P304
P356
10.1159/000326849
P577
2011-06-21T00:00:00Z